Role of bradykinin in angiotensin-converting enzyme knockout mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Xiao, Hong D ^a   Fuchs, Sebastien ^a   Cole, Justin M ^a   Disher, Kevin M ^a   Sutliff, Roy L ^a   Bernstein, Kenneth E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Blood pressure; Urine osmolality

Indexed keywords

ANGIOTENSIN; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; HEMATOCRIT; HORMONE SYNTHESIS; KIDNEY CONCENTRATING CAPACITY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; URINE OSMOLALITY;

EID: 0037686696     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00010.2003     Document Type: Article

References (48)

1. Alfie ME, Yang XP, Hess F, and Carretero OA. Salt-sensitive hypertension in bradykinin B2 receptor knockout mice. Biochem Biophys Res Commun 224: 625-630, 1996.
2. Bernstein KE, Martin BM, Edwards AS, and Bernstein EA. Mouse angiotensin-converting enzyme is a protein composed of two homologous domains. J Biol Chem 264: 11945-11951, 1989.
3. Borkowski JA and Hess JF. Targeted disruption of the mouse B2 bradykinin receptor in embryonic stem cells. Can J Physiol Pharmacol 73: 773-779, 1995.
4. Borkowski JA, Ransom RW, Seabrook GR, Trumbauer M, Chen H, Hill RG, Strader CD, and Hess JF. Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem 270: 13706-13710, 1995.
5. Cervenka L, Harrison-Bernard LM, Dipp S, Primrose G, Imig JD, and El-Dahr SS. Early onset salt-sensitive hypertension in bradykinin B(2) receptor null mice. Hypertension 34: 176-180, 1999.
6. Cervenka L, Maly J, Karasova L, Simova M, Vitko S, Hellerova S, Heller J, and El-Dahr SS Angiotensin II-induced hypertension in bradykinin B2 receptor knockout mice. Hypertension 37: 967-973, 2001.
7. Cole J, Ertoy D, Lin H, Sutliff RL, Ezan E, Guyene TT, Capecchi M, Corvol P, and Bernstein KE. Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest 106: 1391-1398, 2000.
8. Cole JM, Xiao H, Adams J, Disher K, Zhao H, and Bernstein KE. New approaches to genetic manipulation of mice: tissue-specific expression of angiotensin converting enzyme (ACE) (Invited Review). Am J Physiol Renal Physiol 284: F599-F607, 2003.
9. Corvol P, Williams TA, and Soubrier F. Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enzymol 248: 283-305, 1995.
10. Cyr M, Eastlund T, Blais C Jr, Rouleau JL, and Adam A. Bradykinin metabolism and hypotensive transfusion reactions. Transfusion 41: 136-150, 2001.
11. Dendorfer A, Wolfrum S, Wagemann M, Qadri F, and Dominiak P. Pathways of bradykinin degradation in blood and plasma of normotensive and hypertensive rats. Am J Physiol Heart Circ Physiol 280: H2182-H2188, 2001.
12. Duka I, Kintsurashvili E, Gavras I, Johns C, Bresnahan M, and Gavras H. Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension. Circ Res 88: 275-281, 2001.
13. El-Dahr SS, Harrison-Bernard LM, Dipp S, Yosipiv IV, and Meleg-Smith S. Bradykinin B2 null mice are prone to renal dysplasia: gene-environment interactions in kidney development. Physiol Genomics 3: 121-131, 2000.
14. Emanueli C, Angioni GR, Anania V, Spissu A, and Madeddu P. Blood pressure responses to acute or chronic captopril in mice with disruption of bradykinin B2-receptor gene. J Hypertens 15: 1701-1706, 1997.
15. Emanueli C, Maestri R, Corradi D, Marchione R, Minasi A, Tozzi MG, Salis MB, Straino S, Capogrossi MC, Olivetti G, and Madeddu P. Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice. Circulation 100: 2359-2365, 1999.
16. Esther CR, Marino EM, Howard TE, Michaud A, Corvol P, Capecchi MR, and Bernstein KE. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 99: 2375-2385, 1997.
17. Esther CR Jr, Howard TE, Marino EM, Goddard JM, Capecchi MR and Bernstein KE. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74: 953-965, 1996.
18. Gainer JV, Morrow JD, Loveland A, King DJ, and Brown NJ. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 339: 1285-1292, 1998.
19. Gossmann J, Thurmann P, Bachmann T, Weller S, Kachel HG, Schoeppe W, and Scheuermann EH. Mechanism of angiotensin converting enzyme inhibitor-related anemie in renal transplant recipients. Kidney Int 50: 973-978, 1996.
20. Guron G and Friberg P. An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 18: 123-137, 2000.
21. Ignjatovic T, Tan F, Brovkovych V, Skidgel RA, and Erdös EG. Activation of bradykinin B1 receptor by ACE inhibitors. Int Immunopharmacol 2: 1787-1793, 2002.
22. Ishida H, Scicli AG, and Carretero OA. Contributions of various rat plasma peptidases to kinin hydrolysis. J Pharmacol Exp Ther 251: 817-820, 1989.
23. Karlberg BE. Cough and inhibition of the renin-angiotensin system. J Hypertens Suppl 11: S49-S52, 1993.
24. Kokkonen JO, Lindstedt KA, Kuoppala A, and Kovanen PT. Kinin-degrading pathways in the human heart. Trends Cardiovasc Med 10: 42-45, 2000.
25. Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, and Smithies O. Male-female differences in fertility and blood pressure in ACE deficient mice. Nature 375: 146-148, 1991.
26. Kuoppala A, Lindstedt KA, Saarinen J, Kovanen PT, and Kokkonen JO. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma. Am J Physiol Heart Circ Physiol 278: H1069-H1074, 2000.
27. Liao Y, Day KH, Damon DN, and Duling BR. Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci USA 98: 9989-9994, 2001.
28. Linz W, Wiemer G, Gohlke P, Unger T, and Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47: 25-49, 1995.
29. Madeddu P, Varoni MV, Palomba D, Emanueli C, Demontis MP, Glorioso N, Dessi-Fulgheri P, Sarzani R, and Anania V. Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 96: 3570-3578, 1997.
30. Marceau F, Hess JF, and Bachvarov DR. The B1 receptors for kinins. Pharmacol Rev 50: 357-386, 1998.
31. Marin-Castano ME, Schanstra JP, Neau E, Praddaude F, Pecher C, Ader JL, Girolami JP, and Bascands JL. Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment. Circulation 105: 627-632, 2002.
32. Matsuda H, Hayashi K, Arakawa K, Naitoh M, Kubota E, Honda M, Matsumoto A, Suzuki H, Yamamoto T, Kajiya F, and Saruta T. Zonal heterogeneity in action of angiotensinconverting enzyme inhibitor on renal microcirculation: role of intrarenal bradykinin. J Am Soc Nephrol 10: 2272-2282, 1999.
33. Mattson DL and Cowley AW Jr. Kinin actions on renal papillary blood flow and sodium excretion. Hypertension 21: 961-965, 1993.
34. Menton P, Bloch-Faure M, Hagege AA, Ruetten H, Huang W, Bergaya S, Ceiler D, Gehring D, Martins I, Salmon G, Boulanger CM, Nussberger J, Crozatier B, Gase JM, Heudes D, Bruneval P, Doetschman T, Menard J, and Alhenc-Gelas F. Cardiovascular abnormalities with normal blood pressure in tissue kallidrein-deficient mice. Proc Natl Acad Sci USA 98: 2634-2639, 2001.
35. Milia AF, Gross V, Plehm R, De Silva JA Jr, Bader M, and Luft FC. Normal blood pressure and renal function in mice lacking the bradykinin B(2) receptor. Hypertension 37: 1473-1479, 2001.
36. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan AJ, Fogo A, Inagami T, Hogan BLM, and Ichikawa I. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96: 2947-2954, 1995.
37. Raidoo DM, Ramsaroop R, Naidoo S, Muller-Esterl W, and Bhoola KD. Kinin receptors in human vascular tissue: their role in atheromatous disease. Immunopharmacology 36: 153-160, 1997.
38. Regoli D and Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 32: 1-46, 1980.
39. Rhaleb NE, Yang XP, Nanba M, Shesely EG, and Carretero OA. Effect of chronic blockade of the kallikrein-kinin system on the development of hypertension in rats. Hypertension 37: 121-128, 2001.
40. Schmaier AH. The plasma kallikrein-kinin system counterbalances the renin-angiotensin system. J Clin Invest 109: 1007-1009, 2002.
41. Squire IB, O'Kane KP, Anderson N, and Reid JL. Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men. Hypertension 36: 132-136, 2000.
42. Trabold F, Pons S, Hagege AA, Bloch-Faure M, AlhencGelas F, Giudicelli JF, Richer-Giudicelli C, and Meneton P. Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice. Hypertension 40: 90-95, 2002.
43. Tschope C, Gohlke P, Zhu YZ, Linz W, Scholkens B, and Unger T. Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins. J Card Fail 3: 133-148, 1997.
44. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T, and Ichikawa I. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101: 755-760, 1998.
45. Tsuchida S, Miyazaki Y, Matsusaka T, Hunley TE, Inagami T, Fogo A, and Ichikawa I. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature. Kidney Int 56: 509-516, 1999.
46. 2 receptor transgenic mice. Am J Physiol Renal Physiol 278: F484-F491, 2000.
47. Yang HYT, Erdös EG, and levin Y. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 214: 374-376, 1970.
48. Zuscik MJ, Chalothorn D, Hellard D, Deighan C, McGee A, Daly CJ, Waugh DJ, Ross SA, Gaivin RJ, Morehead AJ, Thomas JD, Plow EF, McGrath JC, Piascik MT, and Perez DM. Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptor. J Biol Chem 276: 13738-13743, 2001.